De Keulenaer GW - Search Results

1

Endocardial endothelial dysfunction and heart failure.

Andries LJ, Kaluza G, De Keulenaer GW, Mebazaa A, Brutsaert DL, Sys SU. Andries LJ, et al. Among authors: de keulenaer gw. J Card Fail. 1996 Dec;2(4 Suppl):S195-202. doi: 10.1016/s1071-9164(96)80077-7. J Card Fail. 1996. PMID: 8951579 Review.

2

Endothelin-mediated positive inotropic effect induced by reactive oxygen species in isolated cardiac muscle.

De Keulenaer GW, Andries LJ, Sys SU, Brutsaert DL. De Keulenaer GW, et al. Circ Res. 1995 May;76(5):878-84. doi: 10.1161/01.res.76.5.878. Circ Res. 1995. PMID: 7729005

3

The cardiac endothelium: functional morphology, development, and physiology.

Brutsaert DL, De Keulenaer GW, Fransen P, Mohan P, Kaluza GL, Andries LJ, Rouleau JL, Sys SU. Brutsaert DL, et al. Among authors: de keulenaer gw. Prog Cardiovasc Dis. 1996 Nov-Dec;39(3):239-62. doi: 10.1016/s0033-0620(96)80004-1. Prog Cardiovasc Dis. 1996. PMID: 8970576 Review.

4

Decreased myocardial contractility after damage to endocardial endothelium is not merely caused by loss of endothelin production.

De Keulenaer GW, Fransen P, Brutsaert DL, Sys SU. De Keulenaer GW, et al. Cardiovasc Res. 1995 Nov;30(5):646-7. doi: 10.1016/0008-6363(95)00204-9. Cardiovasc Res. 1995. PMID: 9102230 No abstract available.

5

Cardiac endothelium and myocardial function.

Brutsaert DL, Fransen P, Andries LJ, De Keulenaer GW, Sys SU. Brutsaert DL, et al. Among authors: de keulenaer gw. Cardiovasc Res. 1998 May;38(2):281-90. doi: 10.1016/s0008-6363(98)00044-3. Cardiovasc Res. 1998. PMID: 9709389 Review.

6

Physiopharmacological evaluation of myocardial performance: how to study modulation by cardiac endothelium and related humoral factors?

Sys SU, De Keulenaer GW, Brutsaert DL. Sys SU, et al. Among authors: de keulenaer gw. Cardiovasc Res. 1998 Jul;39(1):136-47. doi: 10.1016/s0008-6363(98)00093-5. Cardiovasc Res. 1998. PMID: 9764195 Review. No abstract available.

7

Pathogenesis of heart failure. Changing conceptual paradigms.

De Keulenaer GW, Brutsaert DL. De Keulenaer GW, et al. Acta Cardiol. 1998;53(3):131-41. Acta Cardiol. 1998. PMID: 9793566 Review.

8

Reappraisal of the multicellular preparation for the in vitro physiopharmacological evaluation of myocardial performance.

Sys SU, De Keulenaer GW, Brutsaert DL. Sys SU, et al. Among authors: de keulenaer gw. Adv Exp Med Biol. 1998;453:441-50; discussion 451. doi: 10.1007/978-1-4684-6039-1_49. Adv Exp Med Biol. 1998. PMID: 9889856 Review.

9

Dilated cardiomyopathy: changing pathophysiological concepts and mechanisms of dysfunction.

De Keulenaer GW, Brutsaert DL. De Keulenaer GW, et al. J Card Surg. 1999 Jan-Feb;14(1):64-74. doi: 10.1111/j.1540-8191.1999.tb00953.x. J Card Surg. 1999. PMID: 10678449 Review.

10

Activation of cardiac endothelium as a compensatory component in endotoxin-induced cardiomyopathy: role of endothelin, prostaglandins, and nitric oxide.

Mebazaa A, De Keulenaer GW, Paqueron X, Andries LJ, Ratajczak P, Lanone S, Frelin C, Longrois D, Payen D, Brutsaert DL, Sys SU. Mebazaa A, et al. Among authors: de keulenaer gw. Circulation. 2001 Dec 18;104(25):3137-44. doi: 10.1161/hc5001.100662. Circulation. 2001. PMID: 11748114

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters